Herpiva 500 & 1000 500 mg, 1 g Tablet
PDF Leaflet Revision Date: 18/02/2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of herpes zoster and recurrent genital herpes.
Dosage (summary)
1 g TID for herpes zoster; 500 mg BID for recurrent genital herpes.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; avoid breastfeeding.
Key Drug Interactions
- Nephrotoxic medicines
- Cimetidine
- Probenecid
Contraindications
- Hypersensitivity to valaciclovir or aciclovir
Common side effects
- Dizziness
- Headache
- Nausea
- Vomiting
- Rashes
Counselling Points
- Avoid intercourse during symptoms
- Maintain hydration
- Monitor for neurological effects
Serious warnings
- Risk of DRESS
- Monitor renal function
Important Disclaimer
The Herpiva 500 & 1000 500 mg, 1 g Tablet professional information leaflet below is the property of Innovata Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
